Combined systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) predicts chemotherapy response and prognosis in locally advanced gastric cancer patients receiving neoadjuvant chemotherapy with PD-1 antibody sintilimab and XELOX: a prospective study

Abstract Background Previous studies have confirmed that systemic immune-inflammatory index (SII) and prognostic nutritional index (PNI) can predict the prognosis and chemotherapy efficacy of various malignant tumors. However, to the best of our knowledge, no study investigated the SII combined with...

全面介紹

書目詳細資料

Principais autores:	Ping’an Ding, Honghai Guo, Chenyu Sun, Peigang Yang, Na Hyun Kim, Yuan Tian, Yang Liu, Pengpeng Liu, Yong Li, Qun Zhao
格式:	Artigo
語言:	Inglês
出版:	BMC 2022-03-01
叢編:	BMC Gastroenterology
主題:	Systemic immune-inflammatory index (SII) Prognostic nutritional index (PNI) Chemosensitivity Immunotherapy Locally advanced gastric cancer
在線閱讀:	https://doi.org/10.1186/s12876-022-02199-9
標簽:	添加標簽 沒有標簽, 成為第一個標記此記錄!